It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Identifying differentially abundant microbes is a common goal of microbiome studies. Multiple methods are used interchangeably for this purpose in the literature. Yet, there are few large-scale studies systematically exploring the appropriateness of using these tools interchangeably, and the scale and significance of the differences between them. Here, we compare the performance of 14 differential abundance testing methods on 38 16S rRNA gene datasets with two sample groups. We test for differences in amplicon sequence variants and operational taxonomic units (ASVs) between these groups. Our findings confirm that these tools identified drastically different numbers and sets of significant ASVs, and that results depend on data pre-processing. For many tools the number of features identified correlate with aspects of the data, such as sample size, sequencing depth, and effect size of community differences. ALDEx2 and ANCOM-II produce the most consistent results across studies and agree best with the intersect of results from different approaches. Nevertheless, we recommend that researchers should use a consensus approach based on multiple differential abundance methods to help ensure robust biological interpretations.
Many microbiome differential abundance methods are available, but it lacks systematic comparison among them. Here, the authors compare the performance of 14 differential abundance testing methods on 38 16S rRNA gene datasets with two sample groups, and show ALDEx2 and ANCOM-II produce the most consistent results.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Douglas, Gavin M 1 ; Hayes, Molly G 2
; MacDonald, Jocelyn 3 ; Desai, Dhwani K 4 ; Allward Nicole 5 ; Jones Casey M A 6 ; Wright, Robyn J 6 ; Dhanani, Akhilesh S 4
; Comeau, André M 4
; Langille, Morgan G, I 7 1 Dalhousie University, Department of Microbiology and Immunology, Halifax, Canada (GRID:grid.55602.34) (ISNI:0000 0004 1936 8200)
2 Dalhousie University, Department of Mathematics and Statistics, Halifax, Canada (GRID:grid.55602.34) (ISNI:0000 0004 1936 8200)
3 Dalhousie University, Department of Computer Science, Halifax, Canada (GRID:grid.55602.34) (ISNI:0000 0004 1936 8200)
4 Dalhousie University, Integrated Microbiome Resource, Halifax, Canada (GRID:grid.55602.34) (ISNI:0000 0004 1936 8200)
5 Dalhousie University, Department of Civil and Resource Engineering, Halifax, Canada (GRID:grid.55602.34) (ISNI:0000 0004 1936 8200)
6 Dalhousie University, Department of Pharmacology, Halifax, Canada (GRID:grid.55602.34) (ISNI:0000 0004 1936 8200)
7 Dalhousie University, Integrated Microbiome Resource, Halifax, Canada (GRID:grid.55602.34) (ISNI:0000 0004 1936 8200); Dalhousie University, Department of Pharmacology, Halifax, Canada (GRID:grid.55602.34) (ISNI:0000 0004 1936 8200)




